LifeVantage Added to the Russell Global(R) and Russell 2000(R) Indexes

LifeVantage Added to the Russell Global(R) and Russell 2000(R) Indexes

SALT LAKE CITY, June 28, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, announced that its stock has been added to the Russell
Global^® and Russell 2000^® Indexes.

Douglas C. Robinson, LifeVantage President and Chief Executive Officer,
stated, "We are pleased with our inclusion in the Russell Indexes, which are
among the most important indexes in the broader market. This will support our
goal of enhancing long-term shareholder value and is expected to provide
greater awareness and visibility of our company among institutional and retail
investors."

The Russell Global^® Indexes represent the investable global equity market and
its segments comprehensively. Consistent with the design of the family of U.S.
Russell Indexes, it represents 98% of the global equity market. The Russell
2000^® Index measures the performance of the small-cap segment of the U.S.
equity universe. The Russell 2000^® is a subset of the Russell 3000^® Index
representing approximately 10% of the total market capitalization of that
index. It includes approximately 2000 of the smallest securities based on a
combination of their market cap and current index membership. The Russell
2000^® Index is constructed to provide a comprehensive and unbiased small-cap
barometer and is completely reconstituted annually to ensure larger stocks do
not distort the performance and characteristics of the true small-cap
opportunity set.

In addition, the Company has been added to the Russell Microcap^® Index, which
measures the performance of the microcap segment of the U.S. equity market.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), is a science based nutraceutical
company, a leader in Nrf2 science and the maker of Protandim®, the Nrf2
Synergizer® patented dietary supplement, TrueScience® Anti-Aging Cream and
LifeVantage^® Canine Health,.LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism, satisfaction or disappointment with
current prospects, as well as words such as "believe," "hopes," "intends,"
"estimates," "expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. Examples of
forward-looking statements include, but are not limited to, statements we make
regarding our inclusion in the Russell Indexes and greater awareness of our
company following our inclusion in the Russell Indexes.Such forward-looking
statements are not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements. These
forward-looking statements are based on the Company's current expectations and
beliefs concerning future events affecting the Company and involve known and
unknown risks and uncertainties that may cause the Company's actual results or
outcomes to be materially different from those anticipated and discussed
herein. These risks and uncertainties include, among others, the Company's
inability to successfully expand our operations in existing and other markets
and thereafter manage our growth; the Company's ability to strengthen its
business in Japan; the Company's reliance on third party suppliers and
manufacturers; the Company's ability to retain independent distributors or to
attract new independent distributors on an ongoing basis; the Company's
ability to expand its product offerings; violations of law or our procedures
by the Company's independent distributors; the potential for third-party and
governmental actions involving the Company's network marketing efforts; the
potential for product liability claims against the Company; the risk that
government regulators and regulations could adversely affect the Company's
business; future laws or regulations may hinder or prohibit the production or
sale of the Company's existing product and any future products; unfavorable
publicity could materially hurt the Company's business; the Company's ability
to access raw materials for its Products as it grows; risks associated with
foreign currency fluctuations; and the Company's ability to protect its
intellectual property rights and the value of its product. These and other
risk factors are discussed in greater detail in the Company's Annual Report on
Form 10-K and its Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to time with
the Securities and Exchange Commission. The Company cautions investors not to
place undue reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company undertakes no
obligation to revise or update these forward-looking statements to reflect
events or circumstances after the date of this document, except as required by
law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         -or-
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo